4.6 Review

Nanotechnology for Cancer Therapy Based on Chemotherapy

期刊

MOLECULES
卷 23, 期 4, 页码 -

出版社

MDPI
DOI: 10.3390/molecules23040826

关键词

chemotherapy; nanoparticles; combination therapy; theranostic nanoparticles; cancer

资金

  1. National Nature Science Foundation of China [81570655, 81770728, 51703178]
  2. China Postdoctoral Science Foundation [2015M580855]
  3. Shaanxi Postdoctoral Science Foundation [2016BSHEDZZ100]
  4. Fundamental Research Funds for the Central Universities [xjj2016084]

向作者/读者索取更多资源

Chemotherapy has been widely applied in clinics. However, the therapeutic potential of chemotherapy against cancer is seriously dissatisfactory due to the nonspecific drug distribution, multidrug resistance (MDR) and the heterogeneity of cancer. Therefore, combinational therapy based on chemotherapy mediated by nanotechnology, has been the trend in clinical research at present, which can result in a remarkably increased therapeutic efficiency with few side effects to normal tissues. Moreover, to achieve the accurate pre-diagnosis and real-time monitoring for tumor, the research of nano-theranostics, which integrates diagnosis with treatment process, is a promising field in cancer treatment. In this review, the recent studies on combinational therapy based on chemotherapy will be systematically discussed. Furthermore, as a current trend in cancer treatment, advance in theranostic nanoparticles based on chemotherapy will be exemplified briefly. Finally, the present challenges and improvement tips will be presented in combination therapy and nano-theranostics.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据